scholarly article | Q13442814 |
P50 | author | Chris J L M Meijer | Q90379336 |
Peter J F Snijders | Q90768556 | ||
P2093 | author name string | Theo J M Helmerhorst | |
Frank Smedts | |||
Patricia Ewing | |||
Astrid Baalbergen | |||
P2860 | cites work | Global cancer statistics | Q22241238 |
Human papillomavirus is a necessary cause of invasive cervical cancer worldwide | Q29617514 | ||
The usefulness of immunohistochemistry in tissue microarrays of Human Papillomavirus negative adenocarcinoma of the uterine cervix | Q30978718 | ||
GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes | Q33950978 | ||
Is human papillomavirus genotype an influencing factor on radiotherapy outcome? Ambiguity caused by an association of HPV 18 genotype and adenocarcinoma histology | Q34990478 | ||
Stage at diagnosis and mortality in patients with adenocarcinoma and adenosquamous carcinoma of the uterine cervix diagnosed as a consequence of cytologic screening | Q35103103 | ||
Prevalence of human papillomavirus DNA in different histological subtypes of cervical adenocarcinoma | Q35745823 | ||
Preferential risk of HPV16 for squamous cell carcinoma and of HPV18 for adenocarcinoma of the cervix compared to women with normal cytology in The Netherlands | Q36613522 | ||
Incidence and survival rate of women with cervical cancer in the Greater Amsterdam area | Q36671743 | ||
A systematic review of the prevalence and attribution of human papillomavirus types among cervical, vaginal, and vulvar precancers and cancers in the United States | Q36983254 | ||
Human papillomavirus (HPV) genotypes and HPV16 variants and risk of adenocarcinoma and squamous cell carcinoma of the cervix | Q37826532 | ||
Cervical adenocarcinoma: moving towards better prevention | Q37943650 | ||
Differences in human papillomavirus type distribution in high-grade cervical intraepithelial neoplasia and invasive cervical cancer in Europe | Q38023288 | ||
International trends in the incidence of cervical cancer: I. Adenocarcinoma and adenosquamous cell carcinomas | Q38503187 | ||
Role of human papillomavirus genotype in prognosis of early-stage cervical cancer undergoing primary surgery. | Q40182618 | ||
Members of the human papillomavirus type 18 family (alpha-7 species) share a common association with adenocarcinoma of the cervix | Q43998286 | ||
Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study | Q45206974 | ||
Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication | Q47860026 | ||
Prevalence of human papillomavirus (HPV) types in cervical cancer 2003-2008 in Stockholm, Sweden, before public HPV vaccination. | Q51023169 | ||
Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention. | Q51257523 | ||
HPV-18 is a poor prognostic factor, unlike the HPV viral load, in patients with stage IB-IIA cervical cancer undergoing radical hysterectomy. | Q51550773 | ||
The role of human papillomavirus in cervical adenocarcinoma carcinogenesis. | Q53402217 | ||
High-risk human papillomavirus seems not involved in DES-related and of limited importance in nonDES related clear-cell carcinoma of the cervix. | Q54368974 | ||
HPV genotyping and HPV16 variant analysis in glandular and squamous neoplastic lesions of the uterine cervix. | Q54438467 | ||
Adenocarcinoma of the uterine cervix: prognostic significance of clinicopathologic parameters, flow cytometry analysis and HPV infection. | Q54544360 | ||
Incidence Trends of Adenocarcinoma of the Cervix in 13 European Countries | Q57027324 | ||
Distribution of human papillomavirus genotypes in cervical intraepithelial neoplasia and invasive cervical cancer in Canada | Q57089348 | ||
Classification of cervical carcinoma | Q70178434 | ||
Analysis of cytomorphologically abnormal cervical scrapes for the presence of 27 mucosotropic human papillomavirus genotypes, using polymerase chain reaction | Q72272090 | ||
Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial | Q81404025 | ||
Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial | Q82586477 | ||
p16 Immunoreactivity in unusual types of cervical adenocarcinoma does not reflect human papillomavirus infection | Q84778960 | ||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | adenocarcinoma | Q356033 |
P304 | page(s) | 530-534 | |
P577 | publication date | 2012-12-19 | |
P1433 | published in | Gynecologic Oncology | Q5625182 |
P1476 | title | HPV-type has no impact on survival of patients with adenocarcinoma of the uterine cervix | |
P478 | volume | 128 |